1.09 million from the same period of 2017. This was due gain on short- term investment of THB 0.77 million. Costs and Gross Profit 1. Program Rights Business Costs of program rights business consist
104.79 1.35 1.3% Total expenses 3,066.16 2,946.38 119.78 4.1% Earning before interest and tax 341.41 279.67 61.74 22.1% Finance cost -4.83 -8.02 3.19 -39.8% Share of profit from investment in associate
1,551.9 40.7 2.4 187.0 12.0 Profit for the period 151.0 138.7 122.1 12.3 8.9 28.9 23.7 Overall, in the Q3–2024, the Company’s total revenue and total operating expenses slightly increased from Q2–2024 and
million, improved by THB 224 million or 13.43% up from 2Q2016 mainly from higher export sales volume which increased by 29.31% The consolidated gross profit was THB 679 million, noticeably improved by THB
of the year. Profit & Loss Analysis (Unit : Million Baht unless otherwise stated) 2019 2018 Change Amount % Change Total Revenues 19,304 17,738 1,566 8.83% Sales and service income 18,389 16,738 1,651
53,444 million, increased by THB 3,137 million over the same period last year. The company’s profit from continuing operations was THB 1,658 million, increased by THB 379 million, and the profit margin for
) (1,174.0) (1,350.7) (1,370.2) 19.5 1.4% (3,808.0) (5,044.3) 1,236.3 32.5% Gross profit 471.6 463.7 464.1 473.3 9.2 2.0% 1,918.9 1,872.7 (46.2) (2.4%) Net gain (loss) on exchange rate (4.6) 86.7 113.7 (142.3
overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative
same period of 2018. II. Share of profit from investments in associates In the second quarter of 2019, the Company’s share of profit from investments in associates was Baht 469 million, which increased
recurring income. The change in the past 3 years is as follows; Unit : Thousand Baht 1st half 2018 1st half 2017 1st half 2016 Income 85,812 31,519 4,931 Net profit 11,630 4,937 549 From year 2016, the Group